<DOC>
	<DOCNO>NCT02006680</DOCNO>
	<brief_summary>The best way measure whether treatment child central precocious puberty work hormone stimulation test ( leuprolide stimulation test ) require injection medication multiple blood draw see hormonal response suppress ( block ) . The hypothesis study random measurement free alpha subunit pituitary glycoprotein , protein related pituitary hormone stimulate puberty , provide adequate alternative leuprolide stimulation testfor monitor efficacy pubertal suppression Supprelin LA速 .</brief_summary>
	<brief_title>Markers Pubertal Suppression During Therapy Precocious Puberty</brief_title>
	<detailed_description>During clinical trial Supprelin LA速 , leuprolide stimulation test perform determine adequacy suppression . However , use stimulation test monitor suppression require expensive medication collection multiple blood sample . Alternative method monitor pubertal suppression gonadotropin release hormone receptor agonist ( GnRHa ) therapy include random trough level Luteinizing Hormone ( LH ) , estradiol inhibin B . Recently , free alpha subunit pituitary glycoprotein ( FASPG ) also show potentially useful marker hormonal suppression ( Hirsch HJ , et al , JCEM 95:2841 , 2010 ) undergo paradoxical rise follow initiation therapy , revert baseline upon completion . In investigator-initiated pilot study evaluate novel marker pubertal suppression child receive standard care gonadotropin release hormone receptor agonist therapy treatment central precocious puberty . Children central precocious puberty select treatment Supprelin LA undergo hormonal test marker pubertal activity placement Supprelin LA insert .</detailed_description>
	<mesh_term>Puberty , Precocious</mesh_term>
	<criteria>Female Age : 3 9 year old , inclusive Diagnosis Central Precocious Rapidly Progressive Puberty Bone Age 1 year advance ( obtain within 6 month screen ) AND Breasts Tanner II great AND One following : Random LH &gt; 1 mIU/mL Leuprolidestimulated LH &gt; 4 mIU/mL Random estradiol &gt; 20 pg/mL Leuprolidestimulated 24 hour estradiol &gt; 20 pg/mL Na誰ve GnRHa therapy Approved receive Supprelin LA速 therapy Have acceptable surrogate capable give consent subject 's behalf . Previous GnRHa therapy Presence peripheral precocious puberty include CAH</criteria>
	<gender>Female</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Central Precocious Puberty</keyword>
	<keyword>Suppression</keyword>
	<keyword>Alpha Subunit</keyword>
	<keyword>Leuprolide Stimulation Test</keyword>
</DOC>